2178 ⎘
Genetically modified animals
Sub-classes:TRANSGENIC RAINBOW SHARK
#2TRANSGENIC BARB
#3METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS
#4TRANSGENIC RAINBOW SHARK
#5MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#6DOUBLE KNOCKOUT (GT/CMAH-KO) PIGS, ORGANS AND TISSUES
#7VACCINE FOR IMMUNOCOMPROMISED HOSTS
#8METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS
#9Transgenic barb
#10TRANSGENIC MOUSE EXPRESSING COMMON HUMAN LIGHT CHAIN
#11METHODS AND COMPOSITIONS FOR MODIFIED FACTOR IX PROTEINS
#12Vaccine for immunocompromised hosts
#13GENE EDITING OF REPRODUCTIVE HORMONES TO REDUCE FERTILITY IN ICTALURUS PUNCTATUS
#14MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#15Composition for modifying target gene
#16HUMAN ARTIFICIAL CHROMOSOME CONTAINING HUMAN ANTIBODY LAMBDA LIGHT CHAIN GENE AND NON-HUMAN ANIMAL CONTAINING THE HUMAN ARTIFICIAL CHROMOSOME CAPABLE OF GENETIC TRANSMISSION
#17HUMANIZED HEART MUSCLE
#18Humanized skeletal muscle
#19Double knockout (GT/CMAH-KO) pigs, organs and tissues
#20Transgenic rainbow shark
#21Therapeutic retroviral vectors for gene therapy
#22METHODS AND COMPOSITIONS FOR MODIFIED FACTOR IX PROTEINS
#23METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY
#24GENERATION OF HEAVY-CHAIN ONLY ANTIBODIES IN TRANSGENIC ANIMALS
#25HUMAN ARTIFICIAL CHROMOSOME CONTAINING HUMAN ANTIBODY LAMBDA LIGHT CHAIN GENE AND NON-HUMAN ANIMAL CONTAINING THE HUMAN ARTIFICIAL CHROMOSOME CAPABLE OF GENETIC TRANSMISSION
#26Ungulates with genetically modified immune systems
#27Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy
#28METHODS AND COMPOSITIONS FOR MODIFIED FACTOR IX PROTEINS
#29Vector for targeting the human Rosa26 gene
#30METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES
#31Fumarylacetoacetate hydrolase (FAH)-deficient and immunodeficient rats and uses thereof
#32METHODS FOR PRODUCING HYPO-ALLERGENIC CATS USING GENE EDITING TECHNOLOGY
#33METHOD FOR PRODUCING FOUNDER ANIMAL FOR REPRODUCING ANIMAL HAVING LETHAL PHENOTYPE CAUSED BY GENE MODIFICATION
#34Transferrin receptor transgenic models
#35METHODS AND COMPOSITIONS FOR MODIFIED FACTOR IX PROTEINS
#36Alzheimer's disease animal model
#37Vector for Nucleic Acid Insertion
#38ADENO-ASSOCIATED VIRUS MEDIATED DELIVERY OF C1EI AS A THERAPY FOR ANGIOEDEMA
#39Therapeutic retroviral vectors for gene therapy
#40Induced extended pluripotent stem cells, method of making and using
#41Humanized skeletal muscle
#42Humanized heart muscle
#43Double knockout (GT/CMAH-KO) pigs, organs and tissues
#44Gene editing of reproductive hormones to sterilize aquatic animals
#45Delivery, use and therapeutic applications of the CRISPR-Cas systems and compositions for modeling competition of multiple cancer mutations in vivo
#46METHOD FOR RECONSTRUCTING A NON-HUMAN ANIMAL EMBRYO
#47Vaccine for immunocompromised hosts
#48G protein coupled receptor 85 and SREB3 knockout mice and uses thereof
#49Genetically modified non-human mammals and cells
#50Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission
#51Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications
#52Methods and compositions for mitochondrial replacement therapy
#53Pancreatic islets of transgenic LEA29Y animals for treating diabetes
#54Method for manufacturing transgenic caenorhabditis elegans with DNA methyltransferase and use thereof
#55Adeno-associated virus mediated delivery of C1E1 as a therapy for angioedema
#56Transgenic transchromosomal rodents for making human antibodies
#57Generation of heavy-chain only antibodies in transgenic animals
#58Alzheimer's disease animal model
#59Fumarylacetoacetate hydrolase (Fah)-deficient and immunodeficient rats and uses thereof
#60Methods of nuclease-based genetic engineering
#61Therapeutic retroviral vectors for gene therapy
#62Stem cell gene targeting
#63METHODS FOR PRODUCING FISH WITH HIGH LIPID CONTENT
#64Double knockout (GT/CMAH-KO) pigs, organs and tissues
#65Orange transgenic fluorescent ornamental fish
#66Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)
#67Rodent comprising mouse artificial chromosome vector
#68Transgenic mouse expressing human apo(a) and human apo(B-100) with disabled vitamin C gene produces human Lp(a)
#69Transgenic transchromosomal rodents for making human antibodies
#70RbAp48 transgenic mice for drug discovery in age-related memory decline
#71Nonhuman mammal whose mtDNA is from a nonhuman mammal resistant to a selected disease or disorder and whose nDNA is from a nonhuman donor mammal more susceptible to the selected disease or disorder
#72Mouse for predicting a behavior of drugs in humans
#73Transgenic animal expressing Alzheimer's tau protein
#74Human antibodies against LPS
#75High affinity leptins and leptin antagonists
#76Methods for inhibiting hematopoiesis with a hedgehog antagonist
#77Treatment of Pompe's Disease
#78HETEROLOGOUS ANTIBODIES WHICH BIND HUMAN CD4
#79USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#80USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#81Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#82USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#83USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#84USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#85Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#86Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
#87Chimeric rat produced using rat embryonic stem cells in the presence of an ES cell differentiation suppressant
#88VIRAL VECTORS ENCODING A DNA REPAIR MATRIX AND CONTAINING A VIRION-ASSOCIATED SITE SPECIFIC MEGANUCLEASE FOR GENE TARGETING
#89Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#90Mouse artificial chromosome vector
#91NOVEL THERAPEUTIC USES OF HUMAN FORMYL PEPTIDE RECEPTOR ANTAGONISTS
#92TRANSGENIC ANIMAL MODEL OF NEURODEGENERATIVE DISORDERS
#93Transgenic pig model of cystic fibrosis
#94Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation
#95Method of predicting a behavior of one or more drugs
#96CUSTOM-MADE MEGANUCLEASE AND USE THEREOF
#97FUNCTIONAL DISRUPTION OF AN IMMUNOGLOBULIN GENE IN AN AVIAN EMBRYONIC STEM CELL
#98MULTIVALENT ENTRAIN-AND-AMPLIFY IMMUNOTHERAPEUTICS FOR CARCINOMA
#99TRUNCATED ACTIVIN TYPE II RECEPTOR AND METHODS OF USE
#100SEX-DETERMINATION AND METHODS OF SPECIFYING SAME
#101Transgenic non-human animals expressing human blood clotting factors and uses thereof
#102PREVENTION AND TREATMENT OF BLOOD COAGULATION-RELATED DISASES
#103Quantitative assay for membrane association of proteins
#104METHOD FOR ENHANCING PRODUCTION OF PATHOGEN-RESISTANT PROTEINS USING BIOREACTOR
#105Methods for testing for caloric restriction (CR) mimetics
#106Anticoagulant fusion protein anchored to cell membrane
#107Therapeutic retroviral vectors for gene therapy
#108Methods for ligation and uses thereof
#109Human CTLA-4 antibodies and their uses
#110Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#111Transgenic Prothrombin And Related Thrombin Precursors And Transgenics, Methods, Compositions, Uses And The Like Relating Thereto
#112Transgenic Aves Producing Human Polyclonal Antibodies
#113Genetically modified non-human mammals and cells
#114THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY
#115THEM5-MODIFIED MODELS OF NON-ALCOHOLIC FATTY LIVER DISEASE
#116Methods concerning PPAR delta and antagonists thereof
#117MODELS OF ERYTHROPOIESIS
#118METHODS FOR PRODUCING FISH WITH HIGH LIPID CONTENT
#119TRANSGENIC ANIMALS AND USES THEREOF
#120Method of identifying a compound for the treatment or prevention of obesity
#121TRANSGENIC ANIMALS AND METHODS OF MAKING RECOMBINANT ANTIBODIES
#122Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related Disorders
#123Human anti-It-2 antibodies derived from transgenic xenomouse
#124METHOD OF TREATING HEARING LOSS USING XIAP
#125TRANSGENIC ANIMALS EXPRESSING ANTIBODIES SPECIFIC FOR GENES OF INTEREST AND USES THEREOF
#126USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#127Method for modifying chromosomes
#128Interleukin 10 receptor, (IL-10R) antibodies
#129TRANSGENIC MICE HAVING A HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PHENOTYPE, EXPERIMENTAL USES AND APPLICATIONS
#130Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#131METHOD OF GENERATING SINGLE VL DOMAIN ANTIBODIES IN TRANSGENIC ANIMALS
#132Efficient Insertion of DNA Into Embryonic Stem Cells
#133Allergic disease model animals
#134Transgenic animal model of neurodegenerative disorders
#135METHOD FOR PRODUCING FOUNDER ANIMAL FOR REPRODUCING ANIMAL HAVING LETHAL PHENOTYPE CAUSED BY GENE MODIFICATION
#136Expression of Xenogenous (Human) Immunoglobulins in cloned, transgenic ungulates
#137Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications
#138TRANSGENIC MAMALS MODIFIELD IN BRI PROTEIN EXPRESSION
#139Animal model, and products and methods useful for the production thereof
#140Truncated activin type II receptor and methods of use
#141Compositions and Methods for Cancer Treatment
#142Functional Disruption Of Avian Immunoglobulin Genes
#143Mammalian artificial chromosome vector comprising human cytochrome P450 gene (cluster) and non-human mammalian animal retaining the same
#144MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYE
#145Use of regulatory sequences for specific, transient expression in neuronal determined cells
#146METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION
#147Use of regulatory sequences for specific, transient expression in neuronal determined cells
#148PRODUCTION OF ANTIBODIES IN AVIAN CELLS
#149PRODUCTS AND THEIR USE FOR THE DIAGNOSIS, PREVENTION AND/OR CARE OF HUMAN AND/OR ANIMAL PATHOLOGIES CHARACTERISED BY THE ANOMALOUS DEPOSITION OF B-AMYLOID AND/OR AMYLOID-LIKE SUBSTANCE IN HUMAN AND/OR ANIMAL ORGANS AND TISSUES, AND SCREENING METHOD FOR DETERMINING THE RISK OF SUCH PATHOLOGIES
#150Methods and compositions for mitochondrial replacement therapy
#151Transgenic trasnchromosomal rodents for making human antibodies
#152Methods of using human tissue factor-producing knock-in mice
#153TRANSGENIC PROTEINS FROM MULTI-GENE SYSTEMS, METHODS, COMPOSITIONS, USES AND THE LIKE RELATING THERETO
#154Method of expanding human hepatocytes in vivo
#155Transgenic non-human animals for pharmacological and toxicological studies
#156Heterologous antibodies which bind human CD4
#157Production of collagen in the milk of transgenic mammals
#158TWO STEP CLUSTER DELETION AND HUMANISATION
#159Transgenic production in bovine saliva
#160Knockin mouse with a disruption in a PXR gene expressing human PXR
#161TRANSGENIC MICE EXPRESSING HUMAN FORMYL PEPTIDE RECEPTOR
#162Using cytosine deaminases to diminish retroelement transfer from pigs to humans
#163Method of obtaining chicken embryonic stem cells
#164Transgenic mice for assessing drug metabolism and toxicity
#165Humanized immunoglobulin loci
#166Transgenic mice expressing humanized VEGF
#167Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus
#168Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#169Transgenic Mice and Use Thereof as an Experimental Model
#170METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
#171Large Animal Model for Human-Like Advanced Atherosclerotic Plaque
#172HUMANISATION OF ANIMALS
#173HUMAN ALBUMIN ANIMAL MODELS FOR DRUG EVALUATION, TOXICOLOGY AND IMMUNOGENICITY STUDIES
#174PIG MODEL FOR PSORIASIS
#175Polynucleotides for enhancing expression of a polynucleotide of interest
#176Immunocompetent xenograft model
#177Treatment of Pompe's Disease
#178Production of heterologous protein in the avian oviduct
#179Ungulates with genetically modified immune systems
#180METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION
#181Truncated tau proteins
#182Transgenic non-human animals expressing a truncated activin type II receptor
#183Human CTLA-4 antibodies and their uses
#184Efficient Somatic Cell Nuclear Transfer In Fish
#185Targeting the Rosa26 gene in human embryonic stem cells
#186CHIMERIC NON-HUMAN ANIMAL
#187Human antibodies derived from immunized xenomice
#188MITOCHONDRIAL-NUCLEAR EXCHANGED CELLS, TISSUES, ORGANS AND ANIMALS
#189Genetically Modified Animal and Use Thereof
#190GENERATION OF HEAVY-CHAIN ONLY ANTIBODIES IN TRANSGENIC ANIMALS
#191Methods for producing a protein using an avian lysozyme promoter
#192Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation
#193Transgenic pig model for a hereditary neurodegenerative autosomal dominant disease
#194Mouse model and treatment of hereditary inclusion body myopathy
#195Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation
#196ES Cell-Derived Mice From Diploid Host Embryo Injection
#197Gene Marker for Evaluating Genetic Ability for Carcass Weight in Bovine and Method for Evaluating Genetic Ability for Carcass Weight Using the Same
#198Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#199Isolated human chromosome 14 fragment encoding immunoglobulin genes
#200Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)
#201ERYTHROPOIETIN ANALOG-IgG FUSION PROTEINS
#202Transgenic non-human animals for pharmacological and toxicological studies
#203Transgenic porcine models of cystic fibrosis
#204Production of high levels of transgenic factor IX without gene rescue, and its therapeutic uses
#205Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof
#206Method of identifying compounds using a transgenic pig model of cystic fibrosis
#207Process of Making Transgenic Mammals That Produce Exogenous Proteins in Milk and Transgenic Mammals Produced Thereby
#208Method of producing xenogenous antibodies using a bovine
#209EXPRESSION OF ACTIVE HUMAN FACTOR IX IN MAMMARY TISSUE OF TRANSGENIC ANIMALS
#210Transgenic Mammals Expressing Human Preproinsulin
#211Genetically modified non-human mammals and cells
#212Methods for detecting the presence of mutant mammalian presenilin protein
#213Process for Producing Exogenous Protein in the Milk of Transgenic Mammals and a Process For Purifying Proteins Therefrom
#214Truncated Activin Type II Receptor and Methods of Use
#215Novel apolipoprotein gene involved in lipid metabolism
#216Use of regulatory sequences for specific, transient expression in neuronal determined cells
#217Tissue Specific Expression of Exogenous Proteins in Transgenic Chickens
#218Transgenic bovine having reduced prion protein activity and uses thereof
#219KINASE ANCHOR PROTEIN MUTEINS, PEPTIDES THEREOF AND RELATED METHODS
#220Antigens Targeted by Pathogenic T Cells in Type 1 Diabetes and Uses Thereof
#221HBM variants that modulate bone mass and lipid levels
#222Method and composition for genetically modifying non-human cells and animals
#223Protein and peptide fragments from mouse telomerase reverse transcriptase
#224BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
#225Targeting constructs for the functional disruption of avian immunoglobulin genes
#226p300 transgenic animal
#227Methods for Diagnosing and Treating Heart Disease
#228MOUSE MODEL COMPRISING AN ENGRAFTED HUMAN SKIN HAVING HYPERSENSITIVITY TO UV-LIGHT
#229USING CYTOSINE DEAMINASES TO DIMINISH RETROELEMENT TRANSFER FROM PIGS TO HUMANS
#230Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse
#231HUMAN ALBUMIN ANIMAL MODELS FOR DRUG EVALUATION, TOXICOLOGY AND IMMUNOGENICITY STUDIES
#232Transgenic animal model of bone mass modulation
#233Chicken growth differentiation factor-8
#234Transgenic Animals for Assessing Drug Metabolism and Toxicity in Man
#235Transgenic Rodents Selectively Expressing Human B1 Bradykinin Receptor Protein
#236Method for modifying chromosomes
#237Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission
#238Transgenic Non-Human Animals Comprising the Human Udp-Glucuronosyltransferase 1A (Ugt1a) Gene Locus and Methods of Using Them
#239Transgenic animal model of neurodegenerative disorders
#240Intervertebral Disc Repair, Methods and Devices Therefor
#241Human Polyclonal Antibodies from Genetically Engineered Animals
#242Antibody specific for mutant presenilin 2 and method of use thereof
#243Methods for identifying modulators of protein kinase C-epsilon (PKC) and method of treatment of aberrant glucose metabolism associated therewith
#244Inducing neurofibrillary tangles in transgenic mice expressing a mutant tau protein
#245Materials and methods relating to improved vaccination strategies
#246G PROTEIN COUPLED RECEPTORS AND USES THEREOF
#247Transgenic mammals having human IG loci including plural Vand Vregions and antibodies produced therefrom
#248Polypeptide, novel DNA and novel antibody
#249Methods of treatment using anti-ERBB antibody-maytansinoid conjugates
#250Vectors having both isoforms of beta-hexosaminidase and uses of the same
#251Treatment of Pompe's disease
#252Transgenic Animals and Methods of Making Recombinant Antibodies
#253Detection and Use of Prolylcarboxypeptidase
#254Suppression of Endogenous Immunoglobulin Expression in Non-Human Transgenic Animals
#255Growth Differentiation Factor-8 Nucleic Acid and Polypeptide from Aquatic Species, and Transgenic Aquatic Species
#256Transgenic animals for assessing drug metabolism and toxicity
#257Method for Improved Transgene Expression
#258Method for detecting candidate alzheimer's disease drug
#259Transgenic mammals having human Ig loci including plural Vand V regions and antibodies produced therefrom
#260Pluripotent cells from rat and other species
#261Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
#262Transgenic Mice Inducing Alzheimer's Disease Expressing Mutant Betactf99
#263Animal Model of Prostate Cancer and Use Thereof
#264Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them
#265Transgenic ungulates capable of human antibody production
#266MODEL FOR NEURODEGENERATIVE DISEASES INVOLVING AMYLOID ACCUMULATION
#267Method for rendering a system immunologically compatible utilizing a nucleic acid construct, a nucleic acid construct for inhibiting or regulating the function of an immune response (Ir) gene and an immunologically compatible system containing a nucleic acid construct for inhibiting or regulating the function of an immune response (Ir) gene
#268Method of proliferation in neurogenic regions
#269Ungulates with genetically modified immune systems
#270Model mouse of Alzheimer's disease expressing FAD APP 716 and use thereof
#271Animal model for identifying agents that inhibit or enhance CTLA4 signaling
#272Transgenic mouse comprising a polynucleotide encoding human or humanized C5aR and methods of production and use
#273Human kinases and polynucleotides encoding the same, and uses thereof
#274GENERATION OF ANIMAL MODELS
#275Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications thereof
#276Anti-migraine treatments
#277Methods for testing for caloric restriction (CR) mimetics
#278Therapeutic agent for fibromyalgia
#279Vertebrate embryonic pattern-inducing proteins, and uses related thereto
#280Cell and transgenic animal modelling human antigenic presentation and their uses
#281Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation
#282Production of a transgenic avian by cytoplasmic injection
#283Expression of cyclin G1 in tumors
#284Methods for treating conditions associated with MASP-2 dependent complement activation
#285HUMAN DISEASE MODELING USING SOMATIC GENE TRANSFER
#286In vivo odorant receptor systems and their uses
#287Anti-migraine spirocycles
#288Spirocyclic anti-migraine compounds
#289Non-terminal method of identifying anti-migraine compounds
#290Follistatin isoforms and uses thereof
#291RANKL antibody-PTH/PTHrP chimeric molecules
#292Method for producing immortalised antibodies-secreting cells
#293Avians containing a lysozyme promoter transgene
#294TRANSGENIC MICE COMPRISING A GENOMIC HUMAN TAU TRANSGENE
#295Methods and compositions for inhibition of immune responses
#296Use of regulatory sequences for specific, transient expression in neuronal determined cells
#297Proteolytic and covalent antibodies
#298Transgenic mouse having an amyloid precursor protein with a modified beta secretase cleavage site
#299Antibodies against epitopes with homology to self antigens, methods of preparation
#300Transgenic mice carrying the HP-2 gene and uses as models for vascular diseases